The	DT
pathogenesis	NN
of	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
progressive	JJ
fibrotic	JJ
lung	NN
disease	NN
with	IN
an	DT
appalling	JJ
prognosis	NN
.	.

The	DT
failure	NN
of	IN
anti-inflammatory	JJ
therapies	NNS
coupled	VBN
with	IN
the	DT
observation	NN
that	IN
deranged	JJ
epithelium	NN
overlies	VBZ
proliferative	JJ
myofibroblasts	NNS
to	TO
form	VB
the	DT
fibroblastic	JJ
focus	NN
has	VBZ
lead	VBN
to	TO
the	DT
emerging	VBG
concept	NN
that	IN
IPF	NN
is	VBZ
a	DT
disease	NN
of	IN
deregulated	VBN
epithelial-mesenchymal	JJ
crosstalk	NN
.	.

IPF	NN
is	VBZ
triggered	VBN
by	IN
an	DT
as	RB
yet	RB
unidentified	JJ
alveolar	JJ
injury	NN
that	WDT
leads	VBZ
to	TO
activation	NN
of	IN
transforming-growth-factor-b	NN
(	(
TGF-b	NN
)	)
and	CC
alveolar	JJ
basement	NN
membrane	NN
disruption	NN
.	.

In	IN
the	DT
presence	NN
of	IN
persisting	VBG
injurious	JJ
pathways	NNS
,	,
or	CC
disrupted	VBN
repair	NN
pathways	NNS
,	,
activated	VBN
TGF-b	NN
can	MD
lead	VB
to	TO
enhanced	VBN
epithelial	JJ
apoptosis	NN
and	CC
epithelial-to-mesenchymal	JJ
transition	NN
(	(
EMT	NN
)	)
as	RB
well	RB
as	IN
fibroblast	NN
,	,
and	CC
fibrocyte	NN
,	,
transformation	NN
into	IN
myofibroblasts	NNS
which	WDT
are	VBP
resistant	JJ
to	TO
apoptosis	NN
.	.

The	DT
resulting	VBG
deposition	NN
of	IN
excess	JJ
disrupted	VBN
matrix	NN
by	IN
these	DT
myofibroblasts	NNS
leads	VBZ
to	TO
the	DT
development	NN
of	IN
IPF	NN
.	.

